Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News ISET 2024

Venous Stents: How to Choose Among the Wealth of Options

Caitlin E. Cox

January 26, 2024

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News CV Team Pro

Thorsten Stender, Cardiovascular Technologist

L.A. McKeown

March 15, 2022

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Michael O'Riordan

February 21, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Daily News

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

Todd Neale

October 14, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Opinion Fellow Talk

Cath Lab Hazards: Combat Them With Knowledge

Ankur Gupta, MD, PhD

November 07, 2018

News Conference News VIVA 2018

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

L.A. McKeown

November 06, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

L.A. McKeown

February 11, 2018

Advertisement

Venous Stents: How to Choose Among the Wealth of Options

Only Half of Revascularized PAD Patients Receive GDMT

June 2022 News Roundup

Thorsten Stender, Cardiovascular Technologist

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Acute MI Symptom Clustering Differs in Men and Women: VIRGO

Venous Stents: Long-term Follow-up Plus a New Contender

Sex-Specific Troponin Cutoffs Find Many More Women With Myocardial Injury

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Cath Lab Hazards: Combat Them With Knowledge

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content